Expression Analysis of Proline Rich 15 (Prr15) in Mouse and Human Gastrointestinal Tumors

D Meunier, K Patra, R Smits, A Hagebarth, A Luttges, R Jaussi, MJ Wieduwilt, L Quintanilla-Fend, H Himmelbauer, Riccardo Fodde, RH Fundele

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Scopus)


Proline rich 15 (Prr15), which encodes a protein of unknown function, is expressed almost exclusively in postmitotic cells both during fetal development and in adult tissues, such as the intestinal epithelium and the testis. To determine if this specific expression is lost in intestinal neoplasias, we examined Prr15 expression by in situ hybridization (ISH) on mouse intestinal tumors caused by different gene mutations, and on human colorectal cancer (CRC) samples. Prr15/PRR15 expression was consistently observed in mouse gastrointestinal (GI) tumors caused by mutations in the Apc gene, as well as in several advanced stage human CRCs. In contrast, no Prr15 expression was detected in intestinal tumors derived from mice carrying mutations in the Smad3, Smad4, or Cdkn1b genes. These findings, combined with the fact that a majority of sporadic human CRCs carry APC mutations, strongly suggest that the expression of Prr15/PRR15 in mouse and human GI tumors is linked, directly or indirectly, to the absence of the APC protein or, more generally, to the disruption of the Wnt signaling pathway. (C) 2010 Wiley-Liss, Inc.
Original languageUndefined/Unknown
Pages (from-to)8-15
Number of pages8
JournalMolecular Carcinogenesis
Issue number1
Publication statusPublished - 2011

Research programs

  • EMC MM-03-24-01
  • EMC MM-04-20-01

Cite this